Choriocarcinoma is characterized as a highly invasive tumor of gestational trophoblastic neoplasia (GTN). It can rapidly progress and metastasize via the hematogenous pathway to distant organs including lungs, vagina, brain, liver, kidney, and gastrointestinal tract, in descending order of frequency. Consequently, the clinical signs can be very different, depending on the site of the lesions. Metastases to choroidal are rarely mentioned in the literature. Its prognosis is generally good when treated. However, we report a young patient, 23 years old diagnosed with metastatic choriocarcinoma 2 months after a complete miscarriage. Two months after her spontaneous miscarriage, she experienced an episode of massive vaginal bleed, fever, hemoptysis and lethargy even with normal daily activity. She completed 1 cycle of intramuscular methotrexate on day 1, 3, 5, 7, 9 initially. However, her condition did not improve and she consequently developed right eye swelling, purulent discharge, blurring of vision and right periorbital redness with worsening of hemoptysis. Ophthalmologic evaluation revealed a metastatic choroidal tumor, and CT scan showed pulmonary haemorrhage and metastatic tumor in both lungs. She developed a life threatening condition which was managed very urgently and meticulously with Etoposide, Methotrexate, Dactinomycin, Cyclophosphamide & Vincristine (EMACO) therapy. Unfortunately, she did not complete all of her proposed treatment cycles and succumbed in intensive care unit. An accurate and prompt diagnosis of gestational choriocarcinoma is crucial as it is a highly chemosensitive tumor type and thus, the disease exhibits a good prognosis, even in advanced stages. However, a number of choriocarcinoma cases are often misdiagnosed due to the atypical symptoms of the disease and a lack of clear radiographical evidence.  Gestational choriocarcinoma with metastasis to the eye is a rare disease and a rare cause of exudative retinal detachment. In general, metastatic choriocarcinoma is highly curable with chemotherapy. However, metastasis to the eye, regardless of the type of tumor, portends a poor prognosis.